Articles from BIOTECH Patent News (February 1, 2004)

1-31 out of 31 article(s)

Title	Type	Words
Advanced Viral Research granted patent for treatment of human infections.		476
Advancis continues to expand patent estate covering antibiotic dosing.		521
Affymetrix and Caliper collaboration to automate microarray technology.		517
Alnylam and Cenix enter into RNAi research service agreement.		640
Alnylam grants RNAx license to key patent in RNA interference.		576
Alnylam licenses gene silencing technology from Cold Spring Harbor.		450
Archemix announces aptamer-based therapeutics agreement with Johnson & Johnson.		310
Atrix licenses prostate cancer products in Korea.	Brief Article	249
Aventis obtains United States patent.	Brief Article	101
Edwards Lifesciences completes acquisition of Percutaneous.		532
Enzon and INEX form partnership for oncology therapy.		1199
Former Vertex patent counsel sentenced to prison for insider trading.		512
Gene Logic obtains United States patent.	Brief Article	82
GenVec collaborates with Cordis for delivery of angiogenic agent.		420
Hoffmann-La Roche obtains United States patent.	Brief Article	89
ID Biomedical announces patent grant for non-live, intranasal vaccine.	Brief Article	263
Ilexus obtains United States patent.	Brief Article	122
Imaging Diagnostic patents laser imaging method.	Brief Article	203
Immunomedics awarded patent for humanized carcinoembryonic antigen antibody.		313
Isotechnika obtains United States patent.	Brief Article	171
Nanogen issued patent for addressable biologic electrode.		434
Neurogen, Merck agreement for pain drugs cleared.	Brief Article	261
Perdigao to use Embrex's vaccination system.		480
Peregrine announces patent grant for angiogenesis therapy.		611
Pharmacopeia collaborates with Schering-Plough on respiratory drug.	Brief Article	247
Protein Design Labs receives license fees for humanized antibodies.		388
Rigel announces issuance of Hepatitis C virus and inflammation patents.		568
Tanox obtains United States patent.	Brief Article	93
Texas A&M obtains United States patent.	Brief Article	170
Three patents issued for NanoBio's antimicrobial nanoemulsion technology.		405
Tokai University obtains United States patent.	Brief Article	90